Skip to main content

Dic Score Calculator

Calculate the ISTH disseminated intravascular coagulation score from labs. Enter values for instant results with step-by-step formulas.

Skip to calculator
Clinical Medicine

Dic Score Calculator

Calculate the ISTH disseminated intravascular coagulation score from laboratory values. Assess platelet count, fibrin markers, PT, and fibrinogen for DIC diagnosis.

Last updated: January 2026Reviewed by NovaCalculator Medical Editorial Team

Calculator

Adjust values & calculate
Prerequisite: The ISTH DIC score requires an underlying disorder known to be associated with DIC (sepsis, trauma, malignancy, obstetric complication, etc.).
Greater than 100,000/uL (0 points)
50,000-100,000/uL (1 point)
Less than 50,000/uL (2 points)
No increase (0 points)
Moderate increase (2 points)
Strong increase (3 points)
Less than 3 seconds prolongation (0 points)
3-6 seconds prolongation (1 point)
Greater than 6 seconds prolongation (2 points)
Greater than 100 mg/dL (0 points)
Less than 100 mg/dL (1 point)
ISTH DIC Score
3/8
Not Overt DIC (Suggestive)
Platelets
1/2
Fibrin Markers
2/3
PT
0/2
Fibrinogen
0/1
Interpretation

Score is suggestive but not confirmatory of overt DIC. Repeat scoring in 1-2 days and monitor clinical status closely. Non-overt DIC may progress to overt DIC, particularly if the underlying cause is not addressed. Consider additional testing and clinical correlation.

Management Steps
1Identify and treat underlying cause
2Repeat ISTH DIC score in 1-2 days
3Monitor platelet trend and coagulation parameters
4Watch for clinical signs of thrombosis or hemorrhage
5Consider preventive anticoagulation if appropriate
Clinical Disclaimer: This calculator is for educational and reference purposes only. DIC diagnosis requires clinical correlation and should be made by qualified hematologists. Treatment decisions must consider the complete clinical picture and underlying etiology.
Your Result
ISTH DIC Score: 3/8 | Not Overt DIC (Suggestive)
Share Your Result
Understand the Math

Formula

ISTH DIC Score = Platelet score (0-2) + Fibrin marker score (0-3) + PT score (0-2) + Fibrinogen score (0-1)

The ISTH scoring system assigns points for four laboratory parameters: platelet count (0 for >100K, 1 for 50-100K, 2 for <50K), fibrin-related markers like D-dimer (0 for normal, 2 for moderate, 3 for strong increase), PT prolongation (0 for <3s, 1 for 3-6s, 2 for >6s), and fibrinogen level (0 for >100 mg/dL, 1 for <100 mg/dL). Score of 5 or greater indicates overt DIC.

Last reviewed: January 2026

Worked Examples

Example 1: Overt DIC in Sepsis

A 65-year-old with gram-negative sepsis has platelets 45,000, D-dimer strongly elevated (>10x ULN), PT prolonged by 5 seconds, and fibrinogen 90 mg/dL. Calculate the ISTH DIC score.
Solution:
Platelet count 45,000 (50-100K range): 1 point D-dimer strongly elevated: 3 points PT prolonged by 5 seconds (3-6 sec range): 1 point Fibrinogen 90 mg/dL (<100): 1 point Total ISTH DIC Score: 1 + 3 + 1 + 1 = 6 Threshold for overt DIC: 5 or greater Diagnosis: Overt DIC
Result: ISTH DIC Score: 6/8 - Compatible with overt DIC; initiate treatment and repeat daily

Example 2: Non-Overt DIC Requiring Monitoring

A 42-year-old with acute pancreatitis has platelets 120,000, D-dimer moderately elevated, PT normal, and fibrinogen 180 mg/dL. Calculate the ISTH DIC score.
Solution:
Platelet count 120,000 (>100K): 0 points D-dimer moderately elevated: 2 points PT not prolonged: 0 points Fibrinogen 180 mg/dL (>100): 0 points Total ISTH DIC Score: 0 + 2 + 0 + 0 = 2 Threshold for overt DIC: 5 or greater Diagnosis: Not overt DIC, suggestive
Result: ISTH DIC Score: 2/8 - Suggestive but not overt DIC; repeat scoring in 1-2 days
Expert Insights

Background & Theory

The Dic Score Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/mยฒ), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 ร— weight in kg) + (6.25 ร— height in cm) โˆ’ (5 ร— age) ยฑ sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.

History

The history behind the Dic Score Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.

Share this calculator

Explore More

Frequently Asked Questions

Disseminated intravascular coagulation (DIC) is a serious and potentially life-threatening condition characterized by widespread activation of the coagulation cascade, leading to the formation of small blood clots throughout the vasculature. This pathological process simultaneously consumes clotting factors and platelets, paradoxically resulting in both thrombosis and hemorrhage. DIC is always a secondary condition triggered by an underlying disorder such as sepsis, severe trauma, obstetric complications, malignancy, or severe transfusion reactions. The condition can present acutely with dramatic bleeding or chronically with predominantly thrombotic manifestations. Early recognition and treatment of the underlying cause are the cornerstones of DIC management.
The International Society on Thrombosis and Haemostasis (ISTH) developed a standardized scoring system for diagnosing overt DIC based on readily available laboratory tests. The scoring algorithm requires an underlying disorder known to be associated with DIC as a prerequisite. Four laboratory parameters are then scored: platelet count (0-2 points based on degree of thrombocytopenia), elevated fibrin-related markers such as D-dimer or fibrin degradation products (0-3 points), prolonged prothrombin time (0-2 points), and fibrinogen level (0-1 point). The maximum possible score is 8 points. A total score of 5 or greater is compatible with overt DIC, while a score below 5 is suggestive but not confirmatory, warranting repeat testing in 1-2 days.
The diagnosis of DIC relies on a combination of laboratory tests that reflect the pathophysiology of simultaneous clotting and bleeding. The ISTH scoring system uses four key tests: platelet count to assess consumption, D-dimer or fibrin degradation products (FDPs) to detect ongoing fibrin formation and breakdown, prothrombin time (PT) to evaluate coagulation factor consumption, and fibrinogen level to assess this critical clotting protein. Additional useful tests include activated partial thromboplastin time (aPTT), thrombin time, antithrombin III levels, protein C levels, and peripheral blood smear showing schistocytes (fragmented red blood cells). Serial monitoring is essential because individual test values may be normal early in DIC, and trending is more informative than single measurements.
DIC can be triggered by numerous underlying conditions across several categories. Infection and sepsis are the most common causes, accounting for approximately 30-40% of cases, with both bacterial (particularly gram-negative) and viral infections implicated. Trauma, including major surgery, burns, and crush injuries, is the second most common trigger through tissue factor release. Obstetric complications including placental abruption, amniotic fluid embolism, eclampsia, and retained dead fetus are important causes in the obstetric population. Malignancies, particularly acute promyelocytic leukemia, mucin-secreting adenocarcinomas, and other solid tumors can trigger DIC. Additional causes include severe transfusion reactions, vascular abnormalities such as large hemangiomas, envenomation from certain snake bites, and severe liver disease.
The treatment of DIC is primarily directed at managing the underlying cause while providing supportive care for the coagulation derangement. Treating the trigger, such as antibiotics for sepsis, delivery of the placenta in obstetric DIC, or chemotherapy for malignancy, is the single most important intervention. Supportive transfusion therapy includes platelet transfusion when counts fall below 10,000 or below 50,000 with active bleeding, cryoprecipitate to maintain fibrinogen above 100 mg/dL, and fresh frozen plasma when there is significant bleeding with prolonged PT. The role of heparin anticoagulation is controversial and generally reserved for cases with predominantly thrombotic manifestations such as purpura fulminans or venous thromboembolism. Antithrombin concentrate and recombinant activated protein C have been studied but are not standard treatments.
Acute and chronic DIC represent different temporal presentations of the same pathological process with distinct clinical features. Acute DIC develops rapidly, often over hours, with dramatic bleeding manifestations including petechiae, ecchymoses, oozing from venipuncture sites, and mucosal bleeding. The laboratory profile shows marked thrombocytopenia, very elevated D-dimer, prolonged PT, and low fibrinogen. Acute DIC is most commonly associated with sepsis, major trauma, and obstetric emergencies. Chronic DIC, also called compensated DIC, develops gradually over weeks to months, allowing the liver to partially compensate for factor consumption. It more commonly presents with thrombotic complications rather than bleeding, and laboratory values may be only mildly abnormal. Chronic DIC is frequently associated with malignancies and retained dead fetus.
Educational Note: This calculator is provided for educational and informational purposes. Results are based on the formulas and inputs provided. Always verify important calculations independently. NovaCalculator processes calculator inputs client-side; optional analytics follow visitor consent settings.Reviewed by: NovaCalculator Medical Editorial Team โ€” Reviewed against WHO, NIH, and peer-reviewed clinical sources. Last reviewed: January 2026. ยฉ 2024โ€“2026 NovaCalculator.

Share this calculator

Formula

ISTH DIC Score = Platelet score (0-2) + Fibrin marker score (0-3) + PT score (0-2) + Fibrinogen score (0-1)

The ISTH scoring system assigns points for four laboratory parameters: platelet count (0 for >100K, 1 for 50-100K, 2 for <50K), fibrin-related markers like D-dimer (0 for normal, 2 for moderate, 3 for strong increase), PT prolongation (0 for <3s, 1 for 3-6s, 2 for >6s), and fibrinogen level (0 for >100 mg/dL, 1 for <100 mg/dL). Score of 5 or greater indicates overt DIC.

Worked Examples

Example 1: Overt DIC in Sepsis

Problem: A 65-year-old with gram-negative sepsis has platelets 45,000, D-dimer strongly elevated (>10x ULN), PT prolonged by 5 seconds, and fibrinogen 90 mg/dL. Calculate the ISTH DIC score.

Solution: Platelet count 45,000 (50-100K range): 1 point\nD-dimer strongly elevated: 3 points\nPT prolonged by 5 seconds (3-6 sec range): 1 point\nFibrinogen 90 mg/dL (<100): 1 point\nTotal ISTH DIC Score: 1 + 3 + 1 + 1 = 6\nThreshold for overt DIC: 5 or greater\nDiagnosis: Overt DIC

Result: ISTH DIC Score: 6/8 - Compatible with overt DIC; initiate treatment and repeat daily

Example 2: Non-Overt DIC Requiring Monitoring

Problem: A 42-year-old with acute pancreatitis has platelets 120,000, D-dimer moderately elevated, PT normal, and fibrinogen 180 mg/dL. Calculate the ISTH DIC score.

Solution: Platelet count 120,000 (>100K): 0 points\nD-dimer moderately elevated: 2 points\nPT not prolonged: 0 points\nFibrinogen 180 mg/dL (>100): 0 points\nTotal ISTH DIC Score: 0 + 2 + 0 + 0 = 2\nThreshold for overt DIC: 5 or greater\nDiagnosis: Not overt DIC, suggestive

Result: ISTH DIC Score: 2/8 - Suggestive but not overt DIC; repeat scoring in 1-2 days

Frequently Asked Questions

What is disseminated intravascular coagulation (DIC)?

Disseminated intravascular coagulation (DIC) is a serious and potentially life-threatening condition characterized by widespread activation of the coagulation cascade, leading to the formation of small blood clots throughout the vasculature. This pathological process simultaneously consumes clotting factors and platelets, paradoxically resulting in both thrombosis and hemorrhage. DIC is always a secondary condition triggered by an underlying disorder such as sepsis, severe trauma, obstetric complications, malignancy, or severe transfusion reactions. The condition can present acutely with dramatic bleeding or chronically with predominantly thrombotic manifestations. Early recognition and treatment of the underlying cause are the cornerstones of DIC management.

How does the ISTH DIC scoring system work?

The International Society on Thrombosis and Haemostasis (ISTH) developed a standardized scoring system for diagnosing overt DIC based on readily available laboratory tests. The scoring algorithm requires an underlying disorder known to be associated with DIC as a prerequisite. Four laboratory parameters are then scored: platelet count (0-2 points based on degree of thrombocytopenia), elevated fibrin-related markers such as D-dimer or fibrin degradation products (0-3 points), prolonged prothrombin time (0-2 points), and fibrinogen level (0-1 point). The maximum possible score is 8 points. A total score of 5 or greater is compatible with overt DIC, while a score below 5 is suggestive but not confirmatory, warranting repeat testing in 1-2 days.

What laboratory tests are used to diagnose DIC?

The diagnosis of DIC relies on a combination of laboratory tests that reflect the pathophysiology of simultaneous clotting and bleeding. The ISTH scoring system uses four key tests: platelet count to assess consumption, D-dimer or fibrin degradation products (FDPs) to detect ongoing fibrin formation and breakdown, prothrombin time (PT) to evaluate coagulation factor consumption, and fibrinogen level to assess this critical clotting protein. Additional useful tests include activated partial thromboplastin time (aPTT), thrombin time, antithrombin III levels, protein C levels, and peripheral blood smear showing schistocytes (fragmented red blood cells). Serial monitoring is essential because individual test values may be normal early in DIC, and trending is more informative than single measurements.

What are the most common causes of DIC?

DIC can be triggered by numerous underlying conditions across several categories. Infection and sepsis are the most common causes, accounting for approximately 30-40% of cases, with both bacterial (particularly gram-negative) and viral infections implicated. Trauma, including major surgery, burns, and crush injuries, is the second most common trigger through tissue factor release. Obstetric complications including placental abruption, amniotic fluid embolism, eclampsia, and retained dead fetus are important causes in the obstetric population. Malignancies, particularly acute promyelocytic leukemia, mucin-secreting adenocarcinomas, and other solid tumors can trigger DIC. Additional causes include severe transfusion reactions, vascular abnormalities such as large hemangiomas, envenomation from certain snake bites, and severe liver disease.

How is the treatment of DIC approached?

The treatment of DIC is primarily directed at managing the underlying cause while providing supportive care for the coagulation derangement. Treating the trigger, such as antibiotics for sepsis, delivery of the placenta in obstetric DIC, or chemotherapy for malignancy, is the single most important intervention. Supportive transfusion therapy includes platelet transfusion when counts fall below 10,000 or below 50,000 with active bleeding, cryoprecipitate to maintain fibrinogen above 100 mg/dL, and fresh frozen plasma when there is significant bleeding with prolonged PT. The role of heparin anticoagulation is controversial and generally reserved for cases with predominantly thrombotic manifestations such as purpura fulminans or venous thromboembolism. Antithrombin concentrate and recombinant activated protein C have been studied but are not standard treatments.

What is the difference between acute and chronic DIC?

Acute and chronic DIC represent different temporal presentations of the same pathological process with distinct clinical features. Acute DIC develops rapidly, often over hours, with dramatic bleeding manifestations including petechiae, ecchymoses, oozing from venipuncture sites, and mucosal bleeding. The laboratory profile shows marked thrombocytopenia, very elevated D-dimer, prolonged PT, and low fibrinogen. Acute DIC is most commonly associated with sepsis, major trauma, and obstetric emergencies. Chronic DIC, also called compensated DIC, develops gradually over weeks to months, allowing the liver to partially compensate for factor consumption. It more commonly presents with thrombotic complications rather than bleeding, and laboratory values may be only mildly abnormal. Chronic DIC is frequently associated with malignancies and retained dead fetus.

References

Reviewed by Rahul Singh, Health & Wellness Specialist ยท Editorial policy